Antiviral activity and safety of 12 weeks of oral treatment with ACH-126, 443 (Beta-L-FD4C) in treatment-naïve patients with chronic HBV infection
J.C. Pottage Jr, S.C. Oshana, P.T. Yen, D. Delic, V. Rehak, S. Plisek, G.M. Mechkov, L.M. DunkleVolume:
38
Year:
2003
Language:
english
DOI:
10.1016/s0168-8278(03)80734-1
File:
PDF, 125 KB
english, 2003